BIOMAT Database Logo BIOMAT Database Logo

Sodium valproate and metyrapone for pituitary-dependent Cushing's disease. 1984

B Glaser, and L Kahana, and V Elias, and M Sheinfeld

UI MeSH Term Description Entries
D008797 Metyrapone An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME. Methbipyranone,Methopyrapone,Metopiron,Metopirone,Métopirone,SU 4885
D010902 Pituitary Gland A small, unpaired gland situated in the SELLA TURCICA. It is connected to the HYPOTHALAMUS by a short stalk which is called the INFUNDIBULUM. Hypophysis,Hypothalamus, Infundibular,Infundibular Stalk,Infundibular Stem,Infundibulum (Hypophysis),Infundibulum, Hypophyseal,Pituitary Stalk,Hypophyseal Infundibulum,Hypophyseal Stalk,Hypophysis Cerebri,Infundibulum,Cerebri, Hypophysis,Cerebrus, Hypophysis,Gland, Pituitary,Glands, Pituitary,Hypophyseal Stalks,Hypophyses,Hypophysis Cerebrus,Infundibular Hypothalamus,Infundibular Stalks,Infundibulums,Pituitary Glands,Pituitary Stalks,Stalk, Hypophyseal,Stalk, Infundibular,Stalks, Hypophyseal,Stalks, Infundibular
D003480 Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. Cushing's Syndrome,Hypercortisolism,Syndrome, Cushing,Syndrome, Cushing's
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000311 Adrenal Glands A pair of glands located at the cranial pole of each of the two KIDNEYS. Each adrenal gland is composed of two distinct endocrine tissues with separate embryonic origins, the ADRENAL CORTEX producing STEROIDS and the ADRENAL MEDULLA producing NEUROTRANSMITTERS. Adrenal Gland,Gland, Adrenal,Glands, Adrenal
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014635 Valproic Acid A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. Dipropyl Acetate,Divalproex,Sodium Valproate,2-Propylpentanoic Acid,Calcium Valproate,Convulsofin,Depakene,Depakine,Depakote,Divalproex Sodium,Ergenyl,Magnesium Valproate,Propylisopropylacetic Acid,Semisodium Valproate,Valproate,Valproate Calcium,Valproate Sodium,Valproic Acid, Sodium Salt (2:1),Vupral,2 Propylpentanoic Acid

Related Publications

B Glaser, and L Kahana, and V Elias, and M Sheinfeld
Sodium valproate and heterogeneity of pituitary dependent Cushing's syndrome.
May 1982, Lancet (London, England),
B Glaser, and L Kahana, and V Elias, and M Sheinfeld
Sodium valproate in Cushing's disease.
July 1984, Lancet (London, England),
B Glaser, and L Kahana, and V Elias, and M Sheinfeld
The combined use of sodium valproate and metyrapone in the treatment of Cushing's syndrome.
April 1988, Clinical endocrinology,
B Glaser, and L Kahana, and V Elias, and M Sheinfeld
Pituitary-dependent Cushing's disease.
April 1977, British medical journal,
B Glaser, and L Kahana, and V Elias, and M Sheinfeld
Pituitary-dependent Cushing's disease.
May 1977, British medical journal,
B Glaser, and L Kahana, and V Elias, and M Sheinfeld
Cyclical Cushing's disease and its successful control under sodium valproate.
December 1990, Journal of endocrinological investigation,
B Glaser, and L Kahana, and V Elias, and M Sheinfeld
Metyrapone test in Cushing's disease.
March 1975, The Journal of clinical endocrinology and metabolism,
B Glaser, and L Kahana, and V Elias, and M Sheinfeld
Primary therapy for Cushing's disease with metyrapone.
March 1986, JAMA,
B Glaser, and L Kahana, and V Elias, and M Sheinfeld
Successful treatment with sodium valproate of a patient with Cushing's disease and gross enlargement of the pituitary.
December 1984, Acta endocrinologica,
B Glaser, and L Kahana, and V Elias, and M Sheinfeld
Metyrapone for Cushing's syndrome.
July 2002, The American journal of psychiatry,
Copied contents to your clipboard!